Inventor
LUO JINQUAN
US51 patents
⚠️ This page may combine multiple inventors who share the name “LUO JINQUAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
JANSSEN BIOTECH INC
31 patentsUS9522957B2Dec 20, 2016
Method of treating an inflammatory condition by administering toll-like 3 receptor antagonists
JANSSEN BIOTECH INC10 citations92
US9212227B2Dec 15, 2015
ST2L antibody antagonists for the treatment of ST2L-mediated inflammatory pulmonary conditions
JANSSEN BIOTECH INC13 citations91
US9090694B2Jul 28, 2015
ST2L antibody antagonists
JANSSEN BIOTECH INC19 citations91
US9862766B2Jan 9, 2018
Method of treating lupus by administering an anti-IL-12 antibody
JANSSEN BIOTECH INC3 citations84
US9428579B2Aug 30, 2016
Method of treating Crohn's disease by administering an anti-IL-12 antibody
JANSSEN BIOTECH INC8 citations84
US9481731B2Nov 1, 2016
Toll-like receptor 3 antagonists
JANSSEN BIOTECH INC9 citations83
US9951137B2Apr 24, 2018
ST2L antagonists and methods of use
JANSSEN BIOTECH INC4 citations82
US10576150B2Mar 3, 2020
Anti-IL-23 antibodies
JANSSEN BIOTECH INC1 citations73
US10272152B2Apr 30, 2019
Anti-IL-23 antibodies, compositions, methods and uses
JANSSEN BIOTECH INC1 citations73
US10759854B2Sep 1, 2020
Interferon alpha and omega antibody antagonists
JANSSEN BIOTECH INC2 citations71
US10450377B2Oct 22, 2019
ST2L antagonists and methods of use
JANSSEN BIOTECH INC1 citations71
US10358491B2Jul 23, 2019
Interferon alpha and omega antibody antagonists
JANSSEN BIOTECH INC1 citations71
US10208113B2Feb 19, 2019
Interferon α and ω antibody antagonists
JANSSEN BIOTECH INC2 citations71
US11746161B2Sep 5, 2023
Antibodies that specifically bind PD-1 and methods of use
JANSSEN BIOTECH INC3 citations68
US10995149B2May 4, 2021
Antibodies that specifically bind PD-1 and methods of use
JANSSEN BIOTECH INC2 citations68
US10844122B2Nov 24, 2020
Prostate specific membrane antigen (PSMA) bispecific binding agents and uses thereof
JANSSEN BIOTECH INC4 citations68
US12084501B2Sep 10, 2024
Proteins comprising CD3 antigen binding domains and uses thereof
JANSSEN BIOTECH INC2 citations66
US11185584B2Nov 30, 2021
Anti-IL-23 antibodies, compositions, methods and uses
JANSSEN BIOTECH INC0 citations62
US9932404B2Apr 3, 2018
Methods of reducing clinical symptoms of viral infection by administering a toll-like receptor 3 antagonist
JANSSEN BIOTECH INC1 citations62
US12161716B2Dec 10, 2024
Anti-IL-23 antibodies, compositions, methods and uses
JANSSEN BIOTECH INC0 citations59
US12077585B2Sep 3, 2024
Proteins comprising kallikrein related peptidase 2 antigen binding domains and their uses
JANSSEN BIOTECH INC0 citations58
US12460001B2Nov 4, 2025
Proteins comprising CD3 antigen binding domains and uses thereof
JANSSEN BIOTECH INC0 citations54
US11787875B2Oct 17, 2023
Materials and methods for improved single chain variable fragments
JANSSEN BIOTECH INC1 citations54
US9714287B2Jul 25, 2017
Anti-IL-23 antibody compositions
JANSSEN BIOTECH INC0 citations52
US9605067B2Mar 28, 2017
Nucleic acids encoding anti-IL-12 antibody
JANSSEN BIOTECH INC0 citations52
US8894990B2Nov 25, 2014
Method for treating psoriatic arthritis by administering an anti-IL-12 antibody
JANSSEN BIOTECH INC0 citations52
US9505837B2Nov 29, 2016
Anti-IL-23 antibodies
JANSSEN BIOTECH INC0 citations51
US9127058B2Sep 8, 2015
Anti-IL-23 Antibodies
JANSSEN BIOTECH INC0 citations51
US9096667B2Aug 4, 2015
Anti-IL-23 antibodies, compositions, methods and uses
JANSSEN BIOTECH INC0 citations51
US10155809B2Dec 18, 2018
Interferon alpha and omega antibody antagonists
JANSSEN BIOTECH INC0 citations50
US9902770B2Feb 27, 2018
Interferon alpha and omega antibody antagonists
JANSSEN BIOTECH INC0 citations50
CUNNINGHAM MARK
5 patentsUS9255153B2Feb 9, 2016
Polynucleotides encoding Toll-Like Receptor 3 antagonists
CUNNINGHAM MARK10 citations91
US9238693B2Jan 19, 2016
Method of treating asthma or reducing inflammatory cell lung inflammation by administering toll-like receptor 3 antibodies
CUNNINGHAM MARK3 citations82
US8540986B2Sep 24, 2013
Toll-like receptor 3 antagonists
CUNNINGHAM MARK2 citations61
US8460659B2Jun 11, 2013
Toll-like receptor 3 antagonists for the treatment of metabolic and cardiovascular diseases
CUNNINGHAM MARK2 citations61
US8409567B2Apr 2, 2013
Toll-like receptor 3 antagonists
CUNNINGHAM MARK2 citations61
JANSSEN PHARMACEUTICA NV
4 patentsUS9850310B2Dec 26, 2017
CD123 binding agents and uses thereof
JANSSEN PHARMACEUTICA NV23 citations90
US11236155B2Feb 1, 2022
Antibodies to pyroglutamate amyloid-β and uses thereof
JANSSEN PHARMACEUTICA NV4 citations70
US12234280B2Feb 25, 2025
Anti-PHF-tau antibodies and uses thereof
JANSSEN PHARMACEUTICA NV0 citations56
US10633435B2Apr 28, 2020
Anti-PHF-tau antibodies and uses thereof
JANSSEN PHARMACEUTICA NV1 citations55
GILES-KOMAR JILL
2 patentsBIOCEROX PROD BV
2 patentsCENTOCOR INC
1 patentCENTOCOR ORTHO BIOTECH INC
1 patentALMAGRO JUAN CARLOS
1 patentUNIV NEW YORK
1 patentBENSON JACQUELINE
1 patentTSUI PING
1 patentShowing the top 50 of 51 patents by PatentIndex Score.